Literature DB >> 23693043

Effects of hyper-early (<12 hours) endovascular treatment of ruptured intracranial aneurysms on clinical outcome.

A Consoli1, G Grazzini, L Renieri, A Rosi, A De Renzis, C Vignoli, S Nappini, F Ammannati, L Capaccioli, S Mangiafico.   

Abstract

Despite the encouraging results obtained with the endovascular treatment of ruptured intracranial aneurysms, few data are available on the effects of the timing of this approach on clinical outcome. The aim of our study was to evaluate the effects of the hyper-early timing of treatment and of pre-treatment and treatment-related variables on the clinical outcome of patients with ruptured intracranial aneurysms. Five hundred and ten patients (167 M, 343 F; mean age 56.45 years) with 557 ruptured intracranial aneurysms were treated at our institution from 2000 to 2011 immediately after their admission. The total population was divided into three groups: patients treated within 12 hours (hyper-early, group A), between 12-48 hours (early, group B) and after 48 hours (delayed, group C). A statistical analysis was carried out for global population and subgroups. Two hundred and thirty-four patients (46%) were included in group A, 172 (34%) in group B and 104 (20%) in group C. Pre-treatment variables (Hunt&Hess, Fisher grades, older age) and procedure-related variable (ischaemic/haemorrhagic complications) showed a significant correlation with worse clinical outcomes. The hyper-early treatment showed no correlation with good clinical outcomes. The incidence of intra-procedural complications was not significantly different between the three groups; 1.2% of pre-treatment rebleedings were observed. The hyper-early endovascular treatment of ruptured intracranial aneurysm does not seem to be statistically correlated with good clinical outcomes although it may reduce the incidence of pre-treatment spontaneous rebleedings without being associated with a higher risk of intra-procedural complications. However, since no significant differences in terms of clinical outcome and pre-treatment rebleeding rate were observed, a hyper-early treatment is not be supported by our data.

Entities:  

Mesh:

Year:  2013        PMID: 23693043      PMCID: PMC3670058          DOI: 10.1177/159101991301900208

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  30 in total

1.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

2.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

3.  Aneurysmal rebleeding : factors associated with clinical outcome in the rebleeding patients.

Authors:  Ki Chul Cha; Jae Hoon Kim; Hee In Kang; Byung Gwan Moon; Seung Jin Lee; Joo Seung Kim
Journal:  J Korean Neurosurg Soc       Date:  2010-02-28

4.  Endovascular treatment of unruptured aneurysms.

Authors:  D Roy; G Milot; J Raymond
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

5.  Sentinel headache and the risk of rebleeding after aneurysmal subarachnoid hemorrhage.

Authors:  Jürgen Beck; Andreas Raabe; Andrea Szelenyi; Joachim Berkefeld; Rüdiger Gerlach; Matthias Setzer; Volker Seifert
Journal:  Stroke       Date:  2006-09-28       Impact factor: 7.914

6.  Factors affecting outcome after surgery for intracranial aneurysm in Glasgow.

Authors:  B Taylor; P Harries; R Bullock
Journal:  Br J Neurosurg       Date:  1991       Impact factor: 1.596

7.  Rebleeding from ruptured intracranial aneurysms in North Eastern Province of Japan. A cooperative study.

Authors:  Yoshihiro Tanno; Mari Homma; Masahiro Oinuma; Namio Kodama; Teiji Ymamoto
Journal:  J Neurol Sci       Date:  2007-05-23       Impact factor: 3.181

8.  Early versus late intracranial aneurysm surgery in subarachnoid hemorrhage.

Authors:  D Chyatte; N C Fode; T M Sundt
Journal:  J Neurosurg       Date:  1988-09       Impact factor: 5.115

9.  Cost-effective outcome for treating poor-grade subarachnoid hemorrhage.

Authors:  Martin J Wilby; Melanie Sharp; Peter C Whitfield; Peter J Hutchinson; David K Menon; Peter J Kirkpatrick
Journal:  Stroke       Date:  2003-09-04       Impact factor: 7.914

10.  International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion.

Authors:  Andrew J Molyneux; Richard S C Kerr; Ly-Mee Yu; Mike Clarke; Mary Sneade; Julia A Yarnold; Peter Sandercock
Journal:  Lancet       Date:  2005 Sep 3-9       Impact factor: 79.321

View more
  2 in total

Review 1.  Basic embolization techniques: tips and tricks.

Authors:  Anna Maria Ierardi; Filippo Piacentino; Filippo Pesapane; Aldo Carnevale; Marco Curti; Federico Fontana; Massimo Venturini; Antonio Pinto; Francesco Gentili; Susanna Guerrini; Massimo De Filippo; Melchiore Giganti; Gianpaolo Carrafiello
Journal:  Acta Biomed       Date:  2020-07-13

2.  Association of Onset-to-Treatment Time With Discharge Destination, Mortality, and Complications Among Patients With Aneurysmal Subarachnoid Hemorrhage.

Authors:  Marie-Jeanne Buscot; Ronil V Chandra; Julian Maingard; Linda Nichols; Leigh Blizzard; Christine Stirling; Karen Smith; Leon Lai; Hamed Asadi; Jens Froelich; Mathew J Reeves; Nova Thani; Amanda Thrift; Seana Gall
Journal:  JAMA Netw Open       Date:  2022-01-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.